Enhanced sialic acid engagement at physiological temperatures by reovirus σ1 mutants facilitates infection of breast cancer cells with low levels of high-affinity receptors
Open Access
- 21 April 2026
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 100 (4) , e0007426
Abstract
Reovirus serotype 3 (T3D PL ) serves as a safe, tractable model for studying fundamental virus-host interactions and is also under investigation as an oncolytic therapy. Many viruses, including reoviruses, use sialic acids as attachment factors in addition to protein receptors; however, the relative contributions of these interactions, particularly at physiological temperatures, remain poorly defined. T3D PL engages sialic acids and JAM-A proteins through the tail and head domains of the σ1 cell attachment protein, respectively. In this study, murine E0771 breast cancer cells were found to resist reovirus infection due to a deficiency in high-affinity receptors. T3D PL bound to E0771 cells at 4°C but not 37°C, revealing that wild-type sialic acid interactions are thermally unstable at physiological temperatures. Exogenous JAM-A expression restored stable binding and infection at 37°C. Notably, engineered reovirus variants lacking the σ1 head domain but possessing either an RGD motif or specific mutations in the sialic acid-binding domain overcame the restriction and could bind and infect E0771 cells efficiently at 37°C. Through neuraminidase treatment and sialic acid-deficient and dependent cell models, enhanced interactions by sialic acid-binding domain mutations were empirically confirmed to be mediated by sialic acid. Serial passaging of σ1-truncated virus rapidly selected for mutations that strengthened sialic acid-binding at 37°C. Together, these findings demonstrate that high-affinity receptor requirements can be bypassed by enhancing interactions at physiological temperatures with sialic acids or through RGD interactions. This work provides insight into how viruses adapt to receptor scarcity and offers a strategy to overcome receptor heterogeneity in oncolytic virotherapy. IMPORTANCE: Reoviruses are promising oncolytic agents, yet clinical efficacy can be hindered by heterogeneous receptor expression in tumors. This study demonstrates that reovirus can bypass high-affinity receptor requirements by optimizing sialic acid interactions or incorporating RGD motifs. Crucially, the data reveal that wild-type reovirus attachment to sialic acids is thermally unstable at physiological temperature (37°C), a restriction masked by traditional 4°C assays. Specific mutations were found to stabilize these interactions at 37°C, providing a mechanistic basis for viral adaptation to receptor-deficient environments. These findings establish new experimental approaches to study attachment at 37°C, which can be applied broadly to discover unanticipated mutational effects on viral entry. Ultimately, evaluating virus-cell attachment under physiological conditions is essential for accurately predicting viral tropism and facilitates the design of next-generation oncolytic therapies better equipped to overcome receptor scarcity and thermal barriers in complex tumor environments.Keywords
This publication has 124 references indexed in Scilit:
- Involvement of sialoglycans in SARS‐COV‐2 infection: Opportunities and challenges for glyco‐based inhibitorsIUBMB Life, 2022
- EO771, is it a well‐characterized cell line for mouse mammary cancer model? Limit and uncertaintyCancer Medicine, 2020
- Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non–small cell lung cancer patients with KRAS‐activated tumorsCancer, 2015
- Beyond RGD: virus interactions with integrinsArchives of Virology, 2015
- Sialic Acid Receptors of Viruses2013
- A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibodyInternational Journal of Cancer, 2012
- JAM‐A expression positively correlates with poor prognosis in breast cancer patientsInternational Journal of Cancer, 2009
- Mammalian Reovirus L2 Gene and λ2 Core Spike Protein Sequences and Whole-Genome Comparisons of Reoviruses Type 1 Lang, Type 2 Jones, and Type 3 DearingVirology, 2001
- Stoichiometry of Reovirus Structural Proteins in Virus, ISVP, and Core ParticlesVirology, 1998
- Reovirus Exists in the Form of 13 Particle Species That Differ in Their Content of Protein σ1Virology, 1994